{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Competing Democratic and Republican proposals to help elderly people with the soaring cost of prescription drugs failed today on the Senate floor, and members of both parties said they would carry the issue into this fall's elections if they could not cobble together a compromise. Neither proposal won the 60 votes needed under Senate budget rules. The vote in favor of the Democratic proposal was 52 to 47. In a similar test of strength on the Republican plan, 48 senators voted yes and 51 voted no.", "headline": {"main": "2 Parties' Plans On Drug Costs Falter in Senate"}, "abstract": "Competing Democratic and Republican proposals to help elderly people with soaring drug costs fail on Senate floor, neither winning 60 votes needed under budget rules; both sides say they will carry issue into elections if they cannot cobble together compromise; photo; Democratic plan would cost $594 billion from 2005 to 2012; Republicans would spend $370 billion, but even that would be biggest expansion of Medicare since its creation in 1965; Democrats want government to set uniform drug benefits, while Republicans would have government subsidize private insurers to provide coverage (M)", "print_page": "1", "word_count": 1343, "_id": "4fd220d18eb7c8105d7a46dd", "snippet": "Competing Democratic and Republican proposals to help elderly people with the soaring cost of prescription drugs failed today on the Senate floor, and members of both parties said they would carry the issue into this fall's elections if they could...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/24/us/2-parties-plans-on-drug-costs-falter-in-senate.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-24T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-9 11 Die in Israeli Airstrike On House of Hamas Leader An Israeli warplane fired a missile into the home of a top leader of the militant group in Gaza City, killing at least 11 people, including several children, and wounding more than 100, Hamas and hospital officials in Gaza said. Israel said it had killed the leader, Sheik Salah Shehada, a founder of the military wing of Hamas and one of Israel's most wanted men, but a senior Hamas political leader said the sheik had survived. A1 Israeli security officials reached a deal with a leading Palestinian moderate, Sari Nusseibeh, to allow him to reopen his office in Jerusalem. A8", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1036, "_id": "4fd220d78eb7c8105d7a4a9f", "snippet": "INTERNATIONAL   A3-9    11 Die in Israeli Airstrike On House of Hamas Leader  An Israeli warplane fired a missile into the home of a top leader of the militant group in Gaza City, killing at least 11 people, including several children, and wounding...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/23/nyregion/news-summary-128902.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2002-07-23T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "To the Editor: I am delighted to see that adherence to taking medication is finally achieving recognition as a serious health care delivery problem (''Improved Drug Regimens Help Patients Take Their Medicine,'' July 16). Until the medical profession, as well as the pharmaceutical industry and insurance plans, recognize that default in taking medication by the patient is their responsibility, progress on this front cannot be made.", "headline": {"main": "Taking Medication"}, "abstract": "New Jersey Medical School National Tuberculosis Center director Lee B Reichman letter praises July 16 article on importance of drug regimens; photo", "print_page": "3", "word_count": 113, "_id": "4fd237d38eb7c8105d7cabed", "snippet": "To the Editor:    I am delighted to see that adherence to taking medication is finally achieving recognition as a serious health care delivery problem (''Improved Drug Regimens Help Patients Take Their Medicine,'' July 16).    Until the medical...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/23/science/l-taking-medication-129747.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "REICHMAN, LEE B"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2002-07-23T00:00:00Z", "section_name": "Science; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Senators said today that they were already developing hybrid versions of the two major proposals for Medicare drug benefits, with the expectation that both would fail when the Senate votes on Tuesday. Both proposals would expand Medicare to provide assistance to the elderly in buying prescription drugs. The Democratic proposal offers more extensive benefits, at a higher cost to the government that is estimated at $594 billion from 2005 to 2012.", "headline": {"main": "Parties Create Separate Plans To Cover Drugs"}, "abstract": "Senate Democrats and Republicans are developing hybrid versions of the two major proposals for Medicare drug benefits, both of which are expected to fail in upcoming vote; Senate leaders say they hope failure will stimulate serious negotiations to create workable compromise (M)", "print_page": "15", "word_count": 545, "_id": "4fd21aca8eb7c8105d799b91", "snippet": "Senators said today that they were already developing hybrid versions of the two major proposals for Medicare drug benefits, with the expectation that both would fail when the Senate votes on Tuesday.    Both proposals would expand Medicare to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/23/us/parties-create-separate-plans-to-cover-drugs.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-23T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "The struggle over prescription drug coverage for the elderly through Medicare is heading toward a showdown in the Senate today with no likelihood that either of two major bills will gather enough support to pass. A failure to act this session would be a blow to the Democrats, who desperately need to pass something to show that the chamber they control can do as well as or better than the Republican-controlled House, which passed a weak prescription drug bill last month. More important, it would be a blow to millions of elderly people who lack insurance coverage for their costly medicines. The best of the Senate bills is the one sponsored by Senators Bob Graham, Edward Kennedy and Zell Miller and endorsed by the Democratic leadership. It provides the most complete coverage at the lowest cost to the beneficiaries. They would pay a premium of $25 a month, a co-payment of only $10 for each generic drug and $40 for each preferred brand-name drug, and no deductible, with an out-of-pocket maximum of $4,000. The bill's chief drawback is that it would be the most expensive for the government, costing some $421 billion over the first six years. Republicans charge that the nation cannot afford it.", "headline": {"main": "The Battle Over Drug Coverage"}, "abstract": "Editorial says struggle over Medicare prescription drug coverage is heading for showdown in Senate with no likelihood that either of two major bills will gather enough support to pass; says failure to pass legislation this session would be blow to millions of elderly people who lack insurance coverage for their costly medicines", "print_page": "18", "word_count": 652, "_id": "4fd21d8e8eb7c8105d79ead8", "snippet": "The struggle over prescription drug coverage for the elderly through Medicare is heading toward a showdown in the Senate today with no likelihood that either of two major bills will gather enough support to pass. A failure to act this session would...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/23/opinion/the-battle-over-drug-coverage.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": null, "document_type": "article", "pub_date": "2002-07-23T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "People who have been following Congressional debates and votes on big issues like energy, trade and prescription drugs might be excused for presuming that something was passed into law. But on all these issues Congress is stuck -- as it is on election reform, a patients' bill of rights, welfare reform and important budgetary issues. Four months before the election, two Congresses are at work in Washington. One is energetically tackling corporate responsibility and the creation of a new Homeland Security Department. The other, immobilized by partisan bickering, seems happier when the Democrats and the Republicans can each pass conflicting legislation, giving them the bragging rights without actually doing anything.", "headline": {"main": "Hurry Up and Wait in Congress"}, "abstract": "Editorial criticizes Congress for failing to act on number of pressing matters, including bills on energy, trade, prescription drugs, election reform, patients' bill of rights, welfare reform and budget; says Democrats in Senate and Republicans in House seem happy to pass conflicting legislation, giving themselves bragging rights without actually doing anything (M)", "print_page": "16", "word_count": 489, "_id": "4fd21d898eb7c8105d79e7ea", "snippet": "People who have been following Congressional debates and votes on big issues like energy, trade and prescription drugs might be excused for presuming that something was passed into law. But on all these issues Congress is stuck -- as it is on...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/22/opinion/hurry-up-and-wait-in-congress.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "ENERGY AND POWER"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "WORKFARE AND EMPLOYMENT OF WELFARE RECIPIENTS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "WELFARE (US)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "ELECTIONS"}], "byline": null, "document_type": "article", "pub_date": "2002-07-22T00:00:00Z", "section_name": "Health; Opinion"}], "meta": {"hits": 26, "offset": 20, "time": 58}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}